Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.08
-$0.04-3.57%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 78.05% | -61.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 78.05% | -61.20% | |||
| Cost of Revenue | 77.68% | -62.91% | |||
| Gross Profit | 81.82% | -26.67% | |||
| SG&A Expenses | -4.81% | -6.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.35% | -14.56% | |||
| Operating Income | 0.93% | 6.49% | |||
| Income Before Tax | 0.76% | 6.75% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.76% | 6.75% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.76% | 6.75% | |||
| EBIT | 0.93% | 6.49% | |||
| EBITDA | 0.93% | 6.50% | |||
| EPS Basic | 1.60% | 12.84% | |||
| Normalized Basic EPS | 1.60% | 12.85% | |||
| EPS Diluted | 1.60% | 12.84% | |||
| Normalized Diluted EPS | 1.60% | 12.85% | |||
| Average Basic Shares Outstanding | 0.89% | 7.00% | |||
| Average Diluted Shares Outstanding | 0.89% | 7.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||